M&A Deal Summary

Cypress Bioscience Acquires Proprius Pharmaceuticals

On February 25, 2008, Cypress Bioscience acquired life science company Proprius Pharmaceuticals for 38M USD

Acquisition Highlights
  • This is Cypress Bioscience’s 1st transaction in the Life Science sector.
  • This is Cypress Bioscience’s largest (disclosed) transaction.
  • This is Cypress Bioscience’s 1st transaction in the United States.
  • This is Cypress Bioscience’s 1st transaction in California.

M&A Deal Summary
Date 2008-02-25
Target Proprius Pharmaceuticals
Sector Life Science
Buyer(s) Cypress Bioscience
Deal Type Add-on Acquisition
Deal Value 38M USD

Target

Proprius Pharmaceuticals

San Diego, California, United States
Proprius Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets personalized medicine solutions in rheumatology and autoimmune diseases.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cypress Bioscience

San Diego, California, United States
Category Company
Sector Life Science
DESCRIPTION

Cypress Bioscience, Inc. is committed to developing and commercializing pharmaceutical products and personalized medicine laboratory services that allow physicians to serve unmet medical needs.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2008) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-08 Cypress Bioscience - Diagnostic Business

San Diego, California, United States

Cypress Bioscience - Diagnostic Business is a provider of diagnostic services.

Sell $8M
Mergr

Product

Company

Legal